...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: link is up
4
Oct 28, 2022 03:57PM
3
Oct 28, 2022 05:06PM
1
Oct 28, 2022 07:00PM

Oct 28, 2022 07:17PM
1
Oct 28, 2022 07:42PM
3
Oct 28, 2022 08:11PM
1
Oct 28, 2022 08:43PM

I will believe DM when a deal from BP is signed sealed and delivered in a press release, all I say is  ""Show me the money!!

No surprise we're not there yet.  It's a process and it's progressing as well as I'd expect.  Good data, tons of studies, pharmas are paying the bills.  They surely wouldn't be doing the latter if they were not optimistic.  The Talazoparib study is especially promising with a decent chance at early approval.  I doubled my ZEN position over the past year so that sums up what I think.


Oct 29, 2022 06:54AM
Share
New Message
Please login to post a reply